Proex Pharmaceuticals

Supplier logo

Proex Pharmaceuticals

🇹🇷 Turkey, Istanbul
5-10 people
Wholesaler/Trading Company
Proex Pharmaceuticals is an independent pharmaceutical wholesaler and exporter headquartered in Istanbul, Turkey. Established as a specialized trading company, the firm operates with a dedicated team of 5 to 10 professionals and generates an annual revenue of under $5 million. The company serves as a strategic partner in the global healthcare supply chain, sourcing high-quality pharmaceutical products exclusively from wholesalers accredited by the Turkish Ministry of Health. The company's extensive product portfolio includes branded pharmaceuticals from multinational manufacturers such as Roche, Pfizer, AstraZeneca, and Sanofi. Proex Pharmaceuticals specializes in high-demand therapeutic areas, including oncology and chemotherapy medicines, orphan drugs for rare diseases, vaccines (such as Havrix and Bexsero), and Turkish generics. Additionally, the company supplies medical equipment and cosmetic dermal fillers, including Botox and Juvederm. Operating in strict adherence to Good Distribution Practices (GDP) rules, Proex Pharmaceuticals provides professional services including International Parallel Trade, International Tenders, and the Named Patient Program (NPP). The company is highly experienced in navigating regional regulations and offers specialized logistics capabilities such as Cold Chain Shipment to ensure product integrity. With a focus on fast response times and competitive pricing, Proex Pharmaceuticals facilitates the distribution of critical medicines to partners and healthcare providers across various global regions.
Industry association memberMember of GDP rules association.
Contact
********************

3

*************

2

Customers

ABBOTT

1
No shipments

***********

No shipments

*****

No shipments

********************

No shipments

******

No shipments

Unlock all 11 customers

Unlock

Ask AI about this supplier

Curious about this supplier? Ask AI for a quick overview.

Key export market

AsiaAsia
EuropeEurope
North AmericaNorth America
OceaniaOceania
South AmericaSouth America
AfricaAfrica
ANCANC

Similar suppliers you may like

Supplier logo

Imexpharm Pharmaceutical Joint Stock Company

🇻🇳 Vietnam
1977
1001-2000 people
Manufacturer/Distributor
High capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide. Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions. As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Vitamin & khoáng chất
Nhóm dùng ngoài
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Diệt trừ ký sinh trùng
Tiểu đường
Tiểu đường
Tiêu hóa gan mật
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Cơ xương khớp
Mắt
Mắt
Supplier logo

Duoc Khoa Pharmaceutical Joint Stock Company

🇻🇳 Vietnam
2003
101-200 people
Manufacturer/Trading Company/Wholesaler/Service Company
Established brand
OEM manufacturer
Shipments
1
Key customer
V R S C
Key market
🇻🇳 Vietnam
Description
Duoc Khoa Pharmaceutical Joint Stock Company is a Hanoi-based manufacturer and trading company established in 2003 with roots in the Hanoi University of Pharmacy. Operating as a versatile B2B partner, the company specializes in the production of pharmaceuticals, medicinal chemicals, and botanical products. Their extensive product portfolio includes health protection foods, functional foods, herbal teas, and specialized personal care items such as the Propobee throat spray line and Yaocare and Elemis shower products for women and infants. With a workforce of 101 to 200 employees and a dedicated R&D team, the company maintains a significant operational footprint that includes a pharmaceutical factory and five production lines. Duoc Khoa Pharmaceutical Joint Stock Company offers comprehensive OEM and contract manufacturing services, supported by ISO 9001 and SA8000 certifications. Beyond its core pharmaceutical focus, the company is involved in the cultivation of medicinal plants, the manufacture of medical equipment, and the production of specialized packaging and flavor extracts. Holding its own export license, the company serves international markets with an annual output value estimated between US$10 Million and US$50 Million.
TPCN DK-BETICS
TPCN DK-BETICS
DK-BETICS GOLD
DK-BETICS GOLD
Desloratadine
Desloratadine
DK-BETICS
DK-BETICS
ORIKY
ORIKY
AGRIN
AGRIN
Eskar Tears
Eskar Tears
DK-BETICS
DK-BETICS
DK BETICS HERBAL TEA
DK BETICS HERBAL TEA
DK-BETICS
DK-BETICS

Explore supplier list

Turn your product ideas into reality today

Get started for free